CD52 expression in mantle cell lymphoma.
Journal Article
Mantle cell lymphoma is one of the most difficult to treat of all the non-Hodgkin's lymphomas. CAMPATH-1H, a humanized monoclonal antibody against the CD52 antigen, has been used with some success in other lymphoproliferative diseases, especially chronic lymphocytic leukemia. This report demonstrates that tumor samples from patients with mantle cell lymphoma express the CD52 antigen and suggests that CAMPATH-1H should be studied in patients with mantle cell lymphoma.
Full Text
Duke Authors
Cited Authors
- Bass, AJ; Gong, J; Nelson, R; Rizzieri, DA
Published Date
- February 2002
Published In
Volume / Issue
- 43 / 2
Start / End Page
- 339 - 342
PubMed ID
- 11999566
Pubmed Central ID
- 11999566
International Standard Serial Number (ISSN)
- 1042-8194
Digital Object Identifier (DOI)
- 10.1080/10428190290006125
Language
- eng
Conference Location
- United States